tiprankstipranks
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
DAWN
Day One Biopharmaceuticals
RESEARCH TOOLSreports
Want to see DAWN full AI Analyst Report?

Day One Biopharmaceuticals (DAWN) Income Statement

462 Followers

Day One Biopharmaceuticals Income Statement

Last quarter (Q4 2025), Day One Biopharmaceuticals's total revenue was $53.72M, an increase of 83.92% from the same quarter last year. In Q4, Day One Biopharmaceuticals's net income was $-21.28M. See Day One Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 158.18M$ 131.16M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 140.97M$ 125.88M$ -383.00K$ -531.00K$ -199.00K
Operating Expenses
$ 268.72M$ 343.15M$ 205.68M$ 146.38M$ 72.54M
Depreciation and Amortization
$ 3.48M$ 2.03M$ 383.00K$ 531.00K$ 199.00K
EBITDA
$ -105.82M$ -86.32M$ -188.53M$ -141.65M$ -72.56M
Operating Income
$ -127.75M$ -217.27M$ -206.06M$ -146.91M$ -72.74M
Other Income/Expenses
$ 18.45M$ 128.92M$ 17.15M$ 4.73M$ -11.00K
Pretax Income
$ -109.30M$ -88.35M$ -188.92M$ -142.18M$ -72.75M
Net Income
$ -107.32M$ -95.50M$ -188.92M$ -142.18M$ -70.64M
Per Share Metrics
Basic EPS
$ -1.04$ -1.02$ -2.37$ -2.02$ -1.14
Diluted EPS
$ -1.04$ -1.02$ -2.37$ -2.02$ -1.14
Weighted Average Shares Outstanding
 103.38M 93.62M 79.77M 65.47M 61.95M
Weighted Average Shares Outstanding (Diluted)
 103.38M 93.62M 79.77M 65.47M 61.95M
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History